Literature DB >> 21543243

The effects on cardio-respiratory and acid-base variables of the anaesthetic alfaxalone in a 2-hydroxypropyl-β-cyclodextrin (HPCD) formulation in sheep.

A Andaluz1, N Felez-Ocaña, L Santos, L Fresno, F García.   

Abstract

The objective of this study was to determine the pharmacodynamic effects in sheep of the anaesthetic alfaxalone in a 2-hydroxypropyl-β-cyclodextrin formulation. Seven Ripollesa sheep, weighing 43.0±6.6 kg, were used in the study. Twenty-four hours after instrumentation, the sheep were anesthetised with alfaxalone (2 mg/kg bodyweight IV) in cyclodextrin. Heart rate, arterial blood pressure, respiratory rate and arterial blood gases were recorded. Alfaxalone administration resulted in minimal cardio-respiratory depression. Time to standing from anaesthesia was 22.0±10.6 min. Apnoea was not observed in any of the sheep. Significant differences from baseline were not observed in respiratory rate or arterial blood pressure. Heart rate increased significantly (P<0.05) immediately after administration, returning to control values at 20 min. The calculated haemoglobin saturation (SO2) decreased significantly during the first 15 min after alfaxalone administration. The arterial pH decreased significantly during the first 30 min of the study, although no significant differences from basal values were observed in the arterial partial pressure of carbon dioxide (PaCO2). The results showed that alfaxalone in 2-hydroxypropyl-β-cyclodextrin administered as an IV bolus at 2 mg/kg produced minimal adverse effects and an uneventful recovery from anaesthesia in sheep. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543243     DOI: 10.1016/j.tvjl.2011.03.017

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  7 in total

1.  Continuous Rate Infusion of Alfaxalone during Ketamine-Xylazine Anesthesia in Rats.

Authors:  Kathleen Heng; James O Marx; Katechan Jampachairsi; Monika K Huss; Cholawat Pacharinsak
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-02-14       Impact factor: 1.232

2.  Determination of the minimum infusion rate of alfaxalone during its co-administration with midazolam in goats.

Authors:  T B Dzikiti; P S Ndawana; G Zeiler; L Bester; L N Dzikiti
Journal:  Vet Rec Open       Date:  2015-02-25

Review 3.  Optimal management of the critically ill: anaesthesia, monitoring, data capture, and point-of-care technological practices in ovine models of critical care.

Authors:  Saul Chemonges; Kiran Shekar; John-Paul Tung; Kimble R Dunster; Sara Diab; David Platts; Ryan P Watts; Shaun D Gregory; Samuel Foley; Gabriela Simonova; Charles McDonald; Rylan Hayes; Judith Bellpart; Daniel Timms; Michelle Chew; Yoke L Fung; Michael Toon; Marc O Maybauer; John F Fraser
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

4.  The use of alfaxalone for short-term anesthesia can confound serum progesterone measurements in the common marmoset: a case report.

Authors:  Maria Daskalaki; Charis Drummer; Rüdiger Behr; Michael Heistermann
Journal:  Primate Biol       Date:  2022-07-27

5.  Maternal and foetal cardiovascular effects of the anaesthetic alfaxalone in 2-hydroxypropyl-β-cyclodextrin in the pregnant ewe.

Authors:  Anna Andaluz; Laura Santos; Félix García; Rosa I Ferrer; Laura Fresno; Xavier Moll
Journal:  ScientificWorldJournal       Date:  2013-10-24

6.  Anesthetic and cardiorespiratory effects of single-bolus intravenous alfaxalone with or without intramuscular xylazine-premedication in calves.

Authors:  Sayed Fathi El-Hawari; Hisashi Sakata; Norihiko Oyama; Jun Tamura; Chika Higuchi; Yusuke Endo; Kenjirou Miyoshi; Tadashi Sano; Kazuyuki Suzuki; Kazuto Yamashita
Journal:  J Vet Med Sci       Date:  2017-12-20       Impact factor: 1.267

7.  The Effect of Xylazine Premedication on the Dose and Quality of Anesthesia Induction with Alfaxalone in Goats.

Authors:  Mahmoud M Abouelfetouh; Lingling Liu; Eman Salah; Rui Sun; Sha Nan; Mingxing Ding; Yi Ding
Journal:  Animals (Basel)       Date:  2021-03-06       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.